View in EDS HTML Full Text PDF Full Text

Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?

Saved in:
Bibliographic Details
Title: Is there an increased risk of severe COVID-19 among patients with systemic lupus erythematosus treated with anifrolumab?
Authors: Breillat, Paul1,2 (AUTHOR), Mathian, Alexis1,2 (AUTHOR), Rozenberg, Flore2 (AUTHOR), Dutheil, Amélie2,3 (AUTHOR), Barbaud, Annick2,3 (AUTHOR), Amoura, Zahir1,2 (AUTHOR), Chasset, François2,3 (AUTHOR) francois.chasset@aphp.fr
Source: Lupus. Mar2023, Vol. 32 Issue 3, p453-455. 3p. 1 Chart.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:09612033
DOI:10.1177/09612033231153536